125 related articles for article (PubMed ID: 16733607)
1. Benefit of aspirin not surpassed by combining clopidogrel with aspirin in dual anti-platelet prevention of atherothrombotic events in high-risk patients : drug trends in cardiology.
Cardiovasc J S Afr; 2006; 17(2):96, 98; discussion 98. PubMed ID: 16733607
[No Abstract] [Full Text] [Related]
2. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Bhatt DL; Topol EJ;
Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
[TBL] [Abstract][Full Text] [Related]
3. Reducing the risk of adverse thrombotic events - The role of aspirin and clopidogrel.
Jackowski L; Stocks N; Rowett D
Aust Fam Physician; 2008 Sep; 37(9):721-3, 725-6. PubMed ID: 18797530
[TBL] [Abstract][Full Text] [Related]
4. Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
Logman JF; Heeg BM; Herlitz J; van Hout BA
Appl Health Econ Health Policy; 2010; 8(4):251-65. PubMed ID: 20578780
[TBL] [Abstract][Full Text] [Related]
5. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: a substudy from the CHARISMA trial.
Weber M; Bhatt DL; Brennan DM; Hankey GJ; Steinhubl SR; Johnston SC; Montalescot G; Mak KH; Fox KA; Easton DJ; Topol EJ; Hamm CW;
Heart; 2011 Apr; 97(8):626-31. PubMed ID: 21393433
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
Chen J; Shi C; Mahoney EM; Dunn ES; Rinfret S; Caro JJ; O'Brien J; El-Hadi W; Bhatt DL; Topol EJ; Cohen DJ
Can J Cardiol; 2011; 27(2):222-31. PubMed ID: 21459271
[TBL] [Abstract][Full Text] [Related]
8. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
Terpening C
J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
[TBL] [Abstract][Full Text] [Related]
9. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
10. Evolving perspectives on clopidogrel in the treatment of ischemic stroke.
Gorelick P; Sechenova O; Hennekens CH
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):245-8. PubMed ID: 17220470
[TBL] [Abstract][Full Text] [Related]
11. Facts and controversies of aspirin and clopidogrel therapy.
Faxon DP; Freedman JE
Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
Erdmann E
Internist (Berl); 2006 Dec; 47(12):1295-7. PubMed ID: 17096154
[No Abstract] [Full Text] [Related]
13. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
Granitskiĭ NA
Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
[No Abstract] [Full Text] [Related]
14. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel for the prevention of atherothrombotic events.
Almanaseer Y; Desai DM
N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16871689
[No Abstract] [Full Text] [Related]
16. Combination of aspirin and clopidogrel for the prevention of thrombosis: implications for the dental practitioner.
Shah PR; Yepes JF; Valenza JA
Gen Dent; 2007; 55(6):517-22. PubMed ID: 18050576
[TBL] [Abstract][Full Text] [Related]
17. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?
Collet JP; Montalescot G
Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel for the prevention of atherothrombotic events.
Rozenman Y
N Engl J Med; 2006 Jul; 355(4):419; author reply 420-1. PubMed ID: 16871688
[No Abstract] [Full Text] [Related]
19. Clopidogrel for the prevention of atherothrombotic events.
Kongsaengdao S; Arayawichanont A
N Engl J Med; 2006 Jul; 355(4):419-20; author reply 420-1. PubMed ID: 16874903
[No Abstract] [Full Text] [Related]
20. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS
Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
